We’re backed by the resources and capabilities of Pfizer, a global leader in innovative small molecule API manufacturing. We have navigated the introduction of 400+ fermentation and chemical synthesis steps and processes.
Can Pfizer help us scale-up for a global, commercial launch?
We sure can. Collaborate with Pfizer CentreOne and access Pfizer’s knowledge and experience of taking products successfully to market.
Justin Divan, Contract Manufacturing, United States
We’re backed by the resources and capabilities of Pfizer, a global leader in innovative small molecule API manufacturing. We have navigated the introduction of 400+ fermentation and chemical synthesis steps and processes.
Pfizer CentreOne Manufacturing Site in Kalamazoo, United States
You can rely on us for high-quality small molecule API manufacturing. Our commercial manufacturing capabilities span Pfizer’s global small molecule portfolio, and we put those resources to work for you.
Our Kalamazoo, Michigan facility serves your small molecule API manufacturing needs, with decades of experience and more than one million kilograms of APIs manufactured every year. Located in the heart of the United States, the site produces APIs and intermediates using Pfizer quality standards – the same that Pfizer uses for its own branded medicines.
With the flexibility to support small clinical or commercial batches as well as scale to commercial volumes, our cGMP pilot facilities can grow with your API demand.
Our team of analytical chemists and engineers are experts at developing and trouble-shooting analytical methods and scaling your process successfully. We collaborate with you to redesign and optimize chemical processes wherever possible. Analytical, engineering and chemistry teams aim to reduce risk so we can manufacture your products reliably at a large scale, as efficiently as possible.
Henry Browning, Process and Product Technology, United States
